Description:
The CRYOVALVE SG PULMONARY HUMAN HEART VALVE is an innovative medical device designed to replace dysfunctional or disease-ridden pulmonary valves in patients. This is an allograft, also known as a homograft, which means that the valve is acquired from human donor tissue. The device is processed using CRYOLIFE INC.'s proprietary SynerGraft technology, a remarkable solution that decellularizes the native heart valves and vessels, making it more compatible for patient implantation.
The primary role of the device is to facilitate and regulate the flow of blood from the right ventricle of the heart to the pulmonary arteries. It can be used as either a standalone valve or in conjunction with a conduit that replaces both valve and the artery if required.
One of the significant benefits of the CRYOVALVE SG PULMONARY HUMAN HEART VALVE is that the SynerGraft technology significantly reduces the potentiality for a patient's immune response. This facilitates the body's acceptance of the new valve, paving the way for optimal recovery.
The CRYOVALVE SG PULMONARY HUMAN HEART VALVE functions by mimicking the mechanism of sincere, naturally occurring human valves. Once it's surgically implanted in place of the original, diseased valve, the CRYOVALVE opens and shuts in synchronization with the heart's rhythm, ensuring smooth, efficient blood flow from the heart, towards the lungs for oxygenation.
With the CRYOVALVE SG PULMONARY HUMAN HEART VALVE, patients have access to a device that offers a high level of biocompatibility, enabling a normal, healthy cardiac function. This efficient solution brings optimal outcomes for those in need of heart valve repair or replacement.
... Read more